The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival of patients (pts) with metastatic bladder cancer (MBC) in the past quarter century: Sobering results from the California Cancer Registry (CCR).
 
Primo Lara
Honoraria - Pfizer
Consulting or Advisory Role - Astex Pharmaceuticals; Clovis Oncology; Exelixis; Halozyme; Immunogen; Janssen; Lilly; LPath; Medivation; Novartis; Pfizer; Sanofi; Teva; US Diagnostic Services
Research Funding - Aragon Pharmaceuticals (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Heat Biologics (Inst); Janssen Biotech (Inst); Millennium (Inst); Oncogenex (Inst); Polaris (Inst)
 
Ann Brunson
No Relationships to Disclose
 
Ralph deVere White
No Relationships to Disclose
 
Marc A. Dall'Era
No Relationships to Disclose
 
Christopher P. Evans
Stock and Other Ownership Interests - Medivation; Oncogenex
Honoraria - Janssen Oncology; Medivation; Sanofi
Consulting or Advisory Role - Janssen Oncology; Medivation; Millennium
Speakers' Bureau - Janssen Oncology; Medivation; Sanofi
Research Funding - Medivation
Travel, Accommodations, Expenses - Astellas Pharma; Janssen Oncology; Medivation; Sanofi
 
Stanley A Yap
No Relationships to Disclose
 
Frederick J. Meyers
No Relationships to Disclose
 
Chong-xian Pan
Stock and Other Ownership Interests - Accelerated Medical Diagnostics; LP Therapeutics
Consulting or Advisory Role - Novartis
Research Funding - Abbott; Altor BioScience; Novartis